Rouxjeane Venter

481 total citations
15 papers, 309 citations indexed

About

Rouxjeane Venter is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Rouxjeane Venter has authored 15 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Rouxjeane Venter's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (9 papers) and Infectious Diseases and Tuberculosis (5 papers). Rouxjeane Venter is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (9 papers) and Infectious Diseases and Tuberculosis (5 papers). Rouxjeane Venter collaborates with scholars based in South Africa, United States and United Kingdom. Rouxjeane Venter's co-authors include Grant Theron, Keertan Dheda, Aliasgar Esmail, Lucas Smith, Greg Calligaro, Robin M. Warren, Jason Limberis, Jonny Peter, Duncan Chanda and Richard Meldau and has published in prestigious journals such as Nature Medicine, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Rouxjeane Venter

14 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rouxjeane Venter South Africa 7 260 214 133 20 17 15 309
Patrick Cudahy United States 9 258 1.0× 204 1.0× 103 0.8× 7 0.3× 15 0.9× 12 303
Riccardo Alagna Italy 11 238 0.9× 165 0.8× 146 1.1× 7 0.3× 11 0.6× 22 301
Rohini Sharma India 9 280 1.1× 232 1.1× 162 1.2× 9 0.5× 14 0.8× 23 343
Alexandra S Richards United Kingdom 7 268 1.0× 180 0.8× 127 1.0× 11 0.6× 30 1.8× 10 304
Binit Kumar Singh India 9 300 1.2× 245 1.1× 150 1.1× 7 0.3× 20 1.2× 24 347
Jessica Mencarini Italy 10 191 0.7× 110 0.5× 65 0.5× 20 1.0× 12 0.7× 27 285
Syed Beenish Rufai India 8 286 1.1× 179 0.8× 175 1.3× 24 1.2× 10 0.6× 15 320
Rahul Thakur India 8 329 1.3× 261 1.2× 105 0.8× 3 0.1× 10 0.6× 10 348
Chris Isaacs United States 4 185 0.7× 139 0.6× 58 0.4× 4 0.2× 15 0.9× 5 237
J Tapia United States 9 373 1.4× 302 1.4× 217 1.6× 7 0.3× 9 0.5× 11 421

Countries citing papers authored by Rouxjeane Venter

Since Specialization
Citations

This map shows the geographic impact of Rouxjeane Venter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rouxjeane Venter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rouxjeane Venter more than expected).

Fields of papers citing papers by Rouxjeane Venter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rouxjeane Venter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rouxjeane Venter. The network helps show where Rouxjeane Venter may publish in the future.

Co-authorship network of co-authors of Rouxjeane Venter

This figure shows the co-authorship network connecting the top 25 collaborators of Rouxjeane Venter. A scholar is included among the top collaborators of Rouxjeane Venter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rouxjeane Venter. Rouxjeane Venter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ghebrekristos, Yonas, Natalie Beylis, Megan Folkerts, et al.. (2025). Xpert MTB/RIF Ultra-resistant and MTBDR plus- susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. Antimicrobial Agents and Chemotherapy. 69(3). e0167124–e0167124. 1 indexed citations
2.
Abdulgader, Shima M., Zaida Palmer, C Naidoo, et al.. (2025). Oral Washes and Tongue Swabs for Xpert MTB/RIF Ultra–Based Tuberculosis Diagnosis in People With and Without the Ability to Make Sputum. Clinical Infectious Diseases. 81(6). e632–e642.
3.
Derendinger, Brigitta, Rouxjeane Venter, Elizabeth M. Streicher, et al.. (2024). Diagnostic Accuracy of LiquidArray MTB-XDR VER 1.0 for the Detection of Mycobacterium tuberculosis Complex, Fluoroquinolone, Amikacin, Ethambutol, and Linezolid Susceptibility. Clinical Infectious Diseases. 81(1). 159–166. 1 indexed citations
4.
Beylis, Natalie, Chad M. Centner, Rouxjeane Venter, et al.. (2023). Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation. The Lancet Microbe. 4(10). e822–e829. 6 indexed citations
5.
Derendinger, Brigitta, Margaretha de Vos, Rouxjeane Venter, et al.. (2022). Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis. Journal of Molecular Diagnostics. 24(5). 494–502. 2 indexed citations
6.
Venter, Rouxjeane, Leigh A. Kotzé, & Nando Ferreira. (2022). A clinician-run 3D-printing laboratory for orthopaedic preoperative planning: an illustrative case series. The South African Orthopaedic Journal (SAOJ). 61(3). 181–186. 1 indexed citations
7.
Beltran, Caroline, et al.. (2022). Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis. Frontiers in Cellular and Infection Microbiology. 12. 1065893–1065893. 4 indexed citations
8.
Driessche, Koen Vanden, Rouxjeane Venter, Judy Caldwell, et al.. (2021). Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?. The Lancet Respiratory Medicine. 9(4). 340–342. 23 indexed citations
9.
Theron, Grant, Jason Limberis, Rouxjeane Venter, et al.. (2020). Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis. Nature Medicine. 26(9). 1435–1443. 47 indexed citations
10.
Venter, Rouxjeane, Brigitta Derendinger, Margaretha de Vos, et al.. (2020). Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk. Scientific Reports. 10(1). 2633–2633. 7 indexed citations
11.
Beltran, Caroline, Tiaan Heunis, Rouxjeane Venter, et al.. (2020). Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Frontiers in Cellular and Infection Microbiology. 10. 443–443. 23 indexed citations
12.
Theron, Grant, Rouxjeane Venter, Lucas Smith, et al.. (2018). False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes. Journal of Clinical Microbiology. 56(3). 75 indexed citations
13.
Venter, Rouxjeane, Helder Bulo, Emilio Bouza, et al.. (2018). Direct genotyping of Mycobacterium tuberculosis from Xpert® MTB/RIF remnants. Tuberculosis. 111. 202–206. 5 indexed citations
14.
Venter, Rouxjeane, Brigitta Derendinger, Margaretha de Vos, et al.. (2017). Mycobacterial genomic DNA from used Xpert MTB/RIF cartridges can be utilised for accurate second-line genotypic drug susceptibility testing and spoligotyping. Scientific Reports. 7(1). 14854–14854. 13 indexed citations
15.
Theron, Grant, Rouxjeane Venter, Greg Calligaro, et al.. (2016). Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?. Clinical Infectious Diseases. 62(8). 995–1001. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Cudahy Breakdown of academic impact, for papers by Riccardo Alagna Breakdown of academic impact, for papers by Rohini Sharma Breakdown of academic impact, for papers by Alexandra S Richards Breakdown of academic impact, for papers by Binit Kumar Singh Breakdown of academic impact, for papers by Jessica Mencarini Breakdown of academic impact, for papers by Syed Beenish Rufai Breakdown of academic impact, for papers by Rahul Thakur Breakdown of academic impact, for papers by Chris Isaacs Breakdown of academic impact, for papers by J Tapia
Rankless by CCL
2026